News

Scientists create world's first black hole bomb in the lab
When British physicist Roger Penrose suggested in 1969 that energy could be pulled from a rotating black hole, it sparked a ...
The Lancet10d
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial
eIsraeli National Hemophilia Center and Thrombosis Unit and The Amalia Biron Thrombosis Research Institute, Sheba Medical Center, Tel Hashomer, Israel fChildren's Hospital Los Angeles, University of ...
C&EN18d
Efficient Determination of Water/Ice Phase Diagram through Isenthalpic–Isobaric Molecular Dynamics Simulations
Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo (USP), Av. Prof. Luciano Gualberto, 380, São Paulo, São Paulo 05508-010, Brazil ...
winbuzzer.com19d
ByteDance Unveils Seedream 3.0 AI Image Generator and SeedEdit AI Image Editor with Enhanced Realism
ByteDance is making a concerted push into the high-end AI image generation space with Seedream 3.0, a model developed ... Complementing the generator is SeedEdit 1.6, a tool enabling text-prompt ...
The Financial Express20d
Delhi Metro Phase 4 Update: 70% work in three corridors complete, DMRC to add 112 kilometres of new metro lines soon
This segment will include three new metro stations ... the first operational section of Phase 4, was inaugurated for public use. On the same day, the foundation stone was laid for the upcoming ...
IEEE27d
Train Diagram for Optimal Evacuation With Self-Adaptive Voltage Loss and Multi-Train Organization Constraints in Autotransformer Supply Systems
Finally, the paper brings forward device models, including Vv transformers, diesel generators, and energy storage systems considering negative sequence current (NSC) endurance, and establishes ...
PipelineReview.com28d
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
YANTAI, China I April 8, 2025 I On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: ...
The American Journal of Managed Care28d
Icotrokinra Shows Clear Skin in 75% of Adolescents With Plaque Psoriasis in Phase 3 Trial
Today, Johnson & Johnson announced promising new phase 3 data for icotrokinra (JNJ-2113), a first-in-class oral interleukin (IL)-23 receptor antagonist, showing that 75% of adolescents with ...